Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | LTA4H | P09960 | 2/20 | 0.49 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.46 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | GBA1 | P04062 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2159817 | 0.96 | LTA4H (0.50) | FFAR1LTA4HPLA2G4AS1PR1S1PR3 | |
| SCHEMBL28549048 | 0.90 | ADRB2 (0.54) | FFAR1LTA4HLMNAL3MBTL1ADRB2 | |
| SCHEMBL28397849 | 0.89 | LTA4H (0.49) | FFAR1LTA4HS1PR1S1PR3S1PR5 | |
| SCHEMBL7037985 | 0.88 | ADRB2 (0.53) | FFAR1LTA4HLMNAL3MBTL1ADRB2 | |
| SCHEMBL14376292 | 0.87 | L3MBTL1 (0.61) | FFAR1LTA4HPLA2G4ALMNAL3MBTL1 | |
| SCHEMBL4944581 | 0.87 | ADRB2 (0.52) | FFAR1LTA4HLMNAL3MBTL1ADRB2 | |
| SCHEMBL13478955 | 0.86 | FFAR1 (0.50) | FFAR1LTA4HPLA2G4AS1PR1S1PR3 | |
| SCHEMBL14375690 | 0.86 | FFAR1 (0.50) | FFAR1LTA4HS1PR1S1PR3S1PR5 | |
| SCHEMBL3257411 | 0.84 | FFAR1 (0.66) | FFAR1S1PR1S1PR3S1PR5LMNA | |
| SCHEMBL28588481 | 0.84 | LMNA (0.56) | FFAR1LTA4HPLA2G4ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8318781-B2 | G-protein-conjugated receptor agonist | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-11-27 | — | — | US | disclosed |
| US-8318781-B2 | G-protein-conjugated receptor agonist | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-11-27 | — | — | US | disclosed |
| US-8318781-B2 | G-protein-conjugated receptor agonist | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-11-27 | — | — | US | disclosed |
| US-20110184031-A1 | G-Protein-Conjugated Receptor Agonist | KYOTO UNIVERSITY (JP) | 2011-07-28 | — | — | US | disclosed |
| US-20110184031-A1 | G-Protein-Conjugated Receptor Agonist | KYOTO UNIVERSITY (JP) | 2011-07-28 | — | — | US | disclosed |
| US-20110184031-A1 | G-Protein-Conjugated Receptor Agonist | KYOTO UNIVERSITY (JP) | 2011-07-28 | — | — | US | disclosed |
| EP-2151236-A1 | G-PROTEIN-CONJUGATED RECEPTOR AGONIST | Japan Science and Technology Agency (JP) | 2010-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184031-A1 | G-Protein-Conjugated Receptor Agonist | GPR119, GPR3, GPR39 | FFAR1 36/4885LTA4H 1804/4885PLA2G4A 1320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.